Evidence map›Paper›PMID 19413140›Full record

ReviewSleep2009

Molecular signatures of obstructive sleep apnea in adults: a review and perspective.

Erna S Arnardottir, Miroslaw Mackiewicz, Thorarinn Gislason, Karen L Teff, Allan I Pack

Open access · bronzeAbstract readReview
In one paragraph

Review in Sleep, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed, 3 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 3 syntheses or guidelines pooled it, 345 citations in OpenAlex.

  1. Pooled it
  2. Effects of Exercise on Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Erna S ArnardottirCenter for Sleep and Respiratory Neurobiology, Division of Sleep Medicine/Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. ernasif@landspitali.is
Miroslaw Mackiewicz
Thorarinn Gislason
Karen L Teff
Allan I Pack
University of Pennsylvania · USNational University Hospital of Iceland · ISSleepMed · USUniversity of Iceland · IS

Funding

SCOR IN NEUROBIOLOGY SLEEP AND SLEEP APNEAP50HL060287 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ABEL, EDWIN TED G · 1998 to 2007
$17.2M
Family Linkage Study of Obstructive Sleep ApneaR01HL072067 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PACK, ALLAN IAN · 2003 to 2007
$5.7M
NHLBI NIH HHS HL60287NHLBI NIH HHS HL72067NHLBI NIH HHS P50 HL060287NHLBI NIH HHS R01 HL072067
6 · The paper itself

Abstract

The consequences of obstructive sleep apnea (OSA) are largely mediated by chronic intermittent hypoxia and sleep fragmentation. The primary molecular domains affected are sympathetic activity, oxidative stress and inflammation. Other affected domains include adipokines, adhesion molecules and molecules that respond to endoplasmic reticulum stress. Changes in molecular domains affected by OSA, assessed in blood and/or urine, can provide a molecular signature for OSA that could potentially be used diagnostically and to predict who is likely to develop different OSA-related comorbidities. High-throughput discovery strategies such as microarrays, assessing changes in gene expression in circulating blood cells, have the potential to find new candidates and pathways thereby expanding the molecular signatures for OSA. More research is needed to fully understand the pathophysiological significance of these molecular signatures and their relationship with OSA comorbidities. Many OSA subjects are obese, and obesity is an independent risk factor for many comorbidities associated with OSA. Moreover, obesity affects the same molecular pathways as OSA. Thus, a challenge to establishing a molecular signature for OSA is to separate the effects of OSA from obesity. We propose that the optimal strategy is to evaluate the temporal changes in relevant molecular pathways during sleep and, in particular, the alterations from before to after sleep when assessed in blood and/or urine. Such changes will be at least partly a consequence of chronic intermittent hypoxia and sleep fragmentation that occurs during sleep.

Indexed as

Gene Expression ProfilingAdipokinesCardiovascular DiseasesContinuous Positive Airway PressureGenetic MarkersHumansHypoxia-Inducible Factor 1, alpha SubunitInflammation MediatorsInsulin ResistanceMetabolomeObesityOligonucleotide Array Sequence AnalysisOxidative StressProteomicsSleep Apnea, ObstructiveSleep DeprivationAdipokinesGenetic MarkersHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitInflammation Mediators

Identifiers

PMID19413140
PMCPMC2663860
OpenAlexW26912437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.